Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Evolving Treatment Landscape of Medullary Thyroid Cancer.
Laganà M, Cremaschi V, Alberti A, Vodopivec Kuri DM, Cosentini D, Berruti A. Laganà M, et al. Among authors: alberti a. Curr Treat Options Oncol. 2023 Dec;24(12):1815-1832. doi: 10.1007/s11864-023-01145-5. Epub 2023 Nov 18. Curr Treat Options Oncol. 2023. PMID: 37979019 Free PMC article. Review.
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors' efficacy: a systematic review and meta-analysis of randomized studies.
Amoroso V, Gallo F, Alberti A, Paloschi D, Ferrari Bravo W, Esposito A, Cosentini D, Grisanti S, Pedersini R, Petrelli F, Berruti A. Amoroso V, et al. Among authors: alberti a. ESMO Open. 2023 Apr;8(2):100787. doi: 10.1016/j.esmoop.2023.100787. Epub 2023 Feb 24. ESMO Open. 2023. PMID: 36842300 Free PMC article. Review.
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study.
Delbarba A, Cosentini D, Facondo P, Laganà M, Pezzaioli LC, Cremaschi V, Alberti A, Grisanti S, Cappelli C, Ferlin A, Berruti A. Delbarba A, et al. Among authors: alberti a. Front Endocrinol (Lausanne). 2023 Apr 5;14:1128061. doi: 10.3389/fendo.2023.1128061. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37077359 Free PMC article.
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis.
Turla A, Laganà M, Cremaschi V, Zamparini M, De Maria L, Consoli F, Abate A, Tamburello M, Alberti A, Sigala S, Grisanti S, Fontanella MM, Cosentini D, Berruti A. Turla A, et al. Among authors: alberti a. J Endocrinol Invest. 2024 Jan;47(1):223-234. doi: 10.1007/s40618-023-02140-1. Epub 2023 Jun 24. J Endocrinol Invest. 2024. PMID: 37354248 Free PMC article.
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy.
Pedersini R, Laganà M, Bosio S, Zanini B, Cosentini D, di Mauro P, Alberti A, Schivardi G, Laini L, Ippolito G, Amoroso V, Vassalli L, Simoncini EL, Berruti A, Donato F. Pedersini R, et al. Among authors: alberti a. Breast Cancer Res Treat. 2023 Dec;202(3):461-471. doi: 10.1007/s10549-023-07095-8. Epub 2023 Sep 11. Breast Cancer Res Treat. 2023. PMID: 37695400 Free PMC article.
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status.
Turla A, Laganà M, Abate A, Cremaschi V, Zamparini M, Chittò M, Consoli F, Alberti A, Ambrosini R, Tamburello M, Grisanti S, Tiberio GAM, Sigala S, Cosentini D, Berruti A. Turla A, et al. Among authors: alberti a. Cancers (Basel). 2023 Sep 9;15(18):4491. doi: 10.3390/cancers15184491. Cancers (Basel). 2023. PMID: 37760461 Free PMC article.
1,128 results